paclitaxel has been researched along with Hyperplasia in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.88) | 18.2507 |
| 2000's | 67 (58.77) | 29.6817 |
| 2010's | 39 (34.21) | 24.3611 |
| 2020's | 7 (6.14) | 2.80 |
| Authors | Studies |
|---|---|
| Emmert, MY; Falk, V; Fernandes, A; Grob, F; Hosseini, V; Mehl, J; Miéville, A; Vogel, V; Yamashita, T | 1 |
| Desai, MA; Parikh, JK; Raval, AJ | 1 |
| Da Zhuang, K; Gogna, A; Irani, FG; Tan, BS; Tay, KH; Too, CW | 1 |
| Akahori, H; Imanaka, T; Ishihara, M; Kimura, T; Miki, K; Tanaka, T; Yanaka, K; Yoshihara, N | 1 |
| Bai, X; Cheng, S; Li, J; Li, S; Xi, J; Zhao, X | 1 |
| Byrne, M; Dear, AE; E Thompson, P; Forsythe, J; Kaye, DM; Liu, H; Mornane, PJ; Mountford, S; Pasic, P; Robinson, A; Rodda, A; Sama, GR; Thissen, H | 1 |
| Buchholz, N; Frank, M; Hakenberg, OW; Kram, W; Kundt, G; Laube, T; Maruschke, M; Nebe, B; Rebl, H; Schnabelrauch, M; Vollmar, B; Wyrwa, R; Zimpfer, A | 1 |
| Chu, C; Liu, M; Liu, S; Long, J; Tan, W; Tang, F; Yang, J; Zeng, O | 1 |
| Akasaka, T; Hirata, K; Imanishi, T; Ino, Y; Ishibashi, K; Kashiwagi, M; Kitabata, H; Komukai, K; Kubo, T; Mizukoshi, M; Takarada, S; Takemoto, K; Tanaka, A; Tanimoto, T | 1 |
| E, Y; Fan, H; He, N | 1 |
| de Boer, SW; de Vries, JP; Elgersma, O; Fioole, B; Heyligers, JM; Karimi, A; Lohle, PN; Nolthenius, RP; van den Heuvel, DA; Vos, JA; Vroegindeweij, D | 1 |
| Buszman, PE; Buszman, PP; Gasior, P; Granada, JF; Jelonek, M; Milewski, K; Pajak, J; Peppas, A; Tellez, A; Zurakowski, A | 1 |
| Clever, YP; Cremers, B; Gershony, G; Scheller, B; Schmitmeier, S; Speck, U | 1 |
| Borghesi, M; Campo, G; Cangiano, E; Cavazza, C; Marchesini, J; Minarelli, M; Parrinello, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P | 1 |
| Buszman, PE; Buszman, PP; Granada, JF; Gwiazdowska-Nowotka, B; Jelonek, M; Krauze, A; Milewski, K; Orlik, B; Pająk, J; Tellez, A; Wojakowski, W | 1 |
| Baek, I; Hwang, J; Kim, DJ; Kim, H; Park, J; Park, JS | 1 |
| Allocco, D; Dawkins, KD; Ellis, SG; Guagliumi, G; Jiang, S; Kobayashi, N; Maehara, A; McAndrew, TC; Mintz, GS; Ormiston, JA; Stone, GW; Turco, MA; Weissman, NJ; Witzenbichler, B | 1 |
| Chang, SH; Chen, WJ; Hsieh, IC; Hsu, MY; Hung, KC; Ko, YS; Lee, CH; Liu, SJ; Wang, CJ; Wen, MS; Yu, CY | 1 |
| Dawkins, KD; Ellis, SG; Grube, E; Kruk, M; Mandinov, L; Mintz, GS; Opolski, MP; Popma, JJ; Pracon, R; Pregowski, J; Stone, GW; Wang, H; Weissman, NJ | 1 |
| Abrignani, S; Altobelli, S; D'Onofrio, A; Da Ros, V; Del Giudice, C; Gandini, R; Sallustio, F; Simonetti, G; Stanzione, P; Vasili, E | 1 |
| Böhm, M; Clever, YP; Cremers, B; Dietz, U; Hauschild, T; Kleber, FX; Scheller, B; Schulz, A; Waliszewski, M | 1 |
| Abadal, JM; Araujo, M; Morales, M; Quintana, M; Toro, A; Vazquez, E | 1 |
| Lee, MS; Sethi, SS | 1 |
| Bergler-Klein, J; Gray, WA; Gyöngyösi, M; Jambrik, Z; Lukovic, D; Maurer, G; Pavo, IJ; Pavo, N; Plass, CA; Sabdyusheva, I; Samaha, E; Stahnke, S; von Strandmann, RP; Zlabinger, K | 1 |
| Christiansen, EH; Galloe, A; Hansen, KN; Jensen, LO; Kelbaek, H; Lassen, JF; Maeng, M; Thayssen, P; Thuesen, L | 1 |
| Mei, L; Song, C; Sun, H | 1 |
| Cho, CH; Han, JM; Kim, JH; Kim, KR; Kim, MH; Lee, SK; Lee, SS; Shin, JH; Shin, KM; Song, HY; Won, YH | 1 |
| Bailey, SR; Cilingiroglu, M; Elicker, J; Elliott, J; Matthews, H; Sangi, P; Tio, F; Trauthen, B | 1 |
| Bonello, L; De Labriolle, A; Lemesle, G; Pakala, R; Scheinowitz, M; Waksman, R | 1 |
| Aoki, J; Cannon, L; Greenberg, J; Grube, E; Koglin, J; Mandinov, L; Mann, JT; Masud, AR; Mintz, GS; Stone, GW; Weissman, NJ | 1 |
| Bruskina, O; Byrne, RA; Iijima, R; Kastrati, A; Mehilli, J; Pinieck, S; Schömig, A | 1 |
| Finn, AV; Kolodgie, FD; Nakazawa, G; Virmani, R | 1 |
| Borovskaya, TG; Borsuk, OS; Daniletz, MG; Goldberg, ED; Goldberg, VE; Masnaya, NV; Pachomova, AV; Perova, AV; Sherstoboev, EY | 1 |
| Inami, S; Mizuno, K; Murakami, D; Ohba, T; Seino, Y; Takano, M; Yamamoto, M | 1 |
| Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Martinez, EE; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG | 1 |
| Chen, ZG; Choi, M; El-Naggar, AK; Khuri, FR; Muller, S; Papadimitrakopoulou, VA; Saba, NF; Shin, DM; Shin, HJ; Tighiouart, M | 1 |
| de Valence, S; Faggian, G; Gurny, R; Innocente, F; Kalangos, A; Mandracchia, D; Mazzucco, A; Moeller, M; Nottelet, B; Pektok, E; Tille, JC; Walpoth, BH | 1 |
| Cho, YK; Han, SW; Hur, SH; Kim, H; Kim, HT; Kim, IC; Kim, KB; Kim, YN; Nam, CW; Park, HS; Yoon, HJ | 1 |
| Inami, S; Mizuno, K; Murakami, D; Ohba, T; Okamatsu, K; Seimiya, K; Seino, Y; Takano, M; Yamamoto, M | 1 |
| Carrie, D; Chevalier, B; Detiege, D; Garcia, E; Hauptmann, KE; Koolen, J; Morice, MC; Nagai, H; Park, SJ; Paunovic, D; Schuler, G; Serruys, PW; Silber, S; Suryapranata, H; van Es, GA; Wijns, W | 1 |
| Bharaj, H; Brodie, BR; Doi, H; Guagliumi, G; Kellett, MA; Kubo, T; Lansky, AJ; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Tsujita, K; Witzenbichler, B; Yang, J | 1 |
| Bezerra, HG; Biondi-Zoccai, G; Costa, MA; Fiocca, L; Guagliumi, G; Lortkipanidze, N; Matiashvili, A; Musumeci, G; Sirbu, V; Suzuki, N; Trivisonno, A; Valsecchi, O | 1 |
| Siminiak, T | 1 |
| AbuSamra, M; Buszman, P; Kałuza, G; Liszka, Ł; Milewski, K; Musioł, E; Pajak, J; Trznadel, S; Zurakowski, A | 1 |
| Ahn, T; Choi, D; Han, SH; Jang, Y; Jeon, DW; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Lee, K; Moon, CI; Oh, SJ; Shin, EK; Yang, JY | 1 |
| Gyöngyösi, M; Hemetsberger, R; Nyolczas, N; Pavo, N; Petnehazy, O; Petrasi, Z; Pósa, A; Sangiorgi, G | 1 |
| Ahn, T; Choi, D; Hong, MK; Jang, Y; Jeon, DW; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Oh, S; Yang, JY | 1 |
| Cook, S; Eberli, FR; Eshtehardi, P; Garachemani, A; Hess, OM; Jüni, P; Lüscher, TF; Meier, B; Räber, L; Togni, M; Vogel, R; Wandel, S; Wenaweser, P; Windecker, S | 1 |
| Ako, J; Chevalier, B; Fitzgerald, PJ; Gray, WA; Grube, E; Hasegawa, T; Henry, TD; Honda, Y; O'Shaughnessy, CD; Ormiston, J; Overlie, P; Schwartz, LB; Sudhir, K; Waseda, K; Whitbourn, R; Yeung, AC | 1 |
| Han, KH; Kang, SJ; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Mintz, GS; Park, DW; Park, SJ; Park, SW | 1 |
| Abizaid, A; Ako, J; Cohen, SA; Courtney, BK; Fitzgerald, PJ; Honda, Y; Macours, N; Ormiston, JA; Otake, H; Popma, JJ; Rogers, C; Shimohama, T; Spaulding, C; Waseda, K | 1 |
| Fujii, K; Gabbiani, G; Hao, H; Hirota, S; Ishibashi-Ueda, H; Shite, J; Tsujimoto, M; Ueda, Y | 1 |
| Cho, JM; Choi, D; Choi, SY; Hong, MK; Jang, Y; Kim, BK; Kim, DM; Kim, JS; Ko, YG; Yoon, JH | 1 |
| Hou, J; Hu, S; Huang, X; Jang, IK; Jia, H; Kong, J; Liu, H; Ma, L; Tian, J; Wu, J; Yu, B; Zhang, M; Zhang, S | 1 |
| Farhan, S; Glogar, D; Gyöngyösi, M; Hemetsberger, R; Huber, K; Karnik, R; Matiasek, J; Nyolczas, N; Petrasi, Z; Plass, C; Schwarzmaier-D'Assie, A; Strehblow, C; Wojta, J | 1 |
| Baek, I; Bai, CZ; Hwang, J; Kim, DJ; Park, J; Park, JS | 1 |
| Abdel-Karim, AR; Addo, T; Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; DaSilva, M; de Lemos, JA; Fasseas, P; Haagen, D; Jeroudi, OM; Kar, B; Karyofillis, P; Lichtenwalter, C; Michael, TT; Obel, O; Raghunathan, D; Rangan, BV; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Voudris, VV | 1 |
| Baek, I; Bai, CZ; Hwang, J; Kim, DJ; Nam, HY; Park, JS | 1 |
| Airaksinen, KE; Karjalainen, PP; Lehtinen, T; Ylitalo, A | 1 |
| Brancati, MF; Burzotta, F; Coluccia, V; Crea, F; De Maria, G; Leone, AM; Niccoli, G; Porto, I; Schiavoni, G; Tommasino, A; Trani, C | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Lima-Filho, MO; Sakurai, R; Shimohama, T; Stone, GW; Sudhir, K; Tsujino, I; Waseda, K; Yamasaki, M | 1 |
| Fitzgerald, PJ; Honda, Y; Kume, T; Nakatani, D; Otake, H; Sakata, K; Waseda, K; Yock, PG | 1 |
| Fearnot, NE; Han, KH; Hong, MK; Kang, DH; Kim, JJ; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Song, JK; Song, JM; Weissman, NJ | 1 |
| Choi, D; Ho, DS; Hong, MK; Jang, Y; Lam, R; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Raizner, AE; Shim, WH; Weissman, NJ | 1 |
| Fearnot, NE; Hong, MK; Kim, JJ; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Tinana, A; Weissman, NJ | 1 |
| Belardi, J; Bilodeau, L; Chan, C; Colombo, A; Dawkins, K; Degertekin, M; Disco, C; Grube, E; Guagliumi, G; Kelbaek, H; Koglin, J; Munzel, T; Ormiston, J; Roy, L; Russell, ME; Ruzyllo, W; Serruys, PW; Strauss, BH; Tanabe, K | 1 |
| Feldman, LJ; Gouëffic, Y; Mazighi, M; Scheuble, A | 1 |
| Cho, MC; Kim, DW; Kim, MS; Kim, YG; Kwon, JS; Lee, GS; Youn, TJ | 1 |
| Machan, L | 1 |
| Escolar, E; Fearnot, NE; Hong, MK; Kim, JJ; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Weissman, NJ | 1 |
| Camenzind, E; Chevalier, B; De Scheerder, I; Fearnot, NE; Gershlick, AH; Goy, JJ; Ho, DS; Kałuza, GL; Missault, L; Park, SJ; Raizner, AE; Reifart, N; Shim, WH; Urban, P; Voorhees, WD; Vrints, C | 1 |
| Chan, C; Wong, A | 1 |
| Burns, GL; Cheung, AK; Chirananthavat, T; Holman, J; Kern, S; Kim, SJ; Kim, SW; Leypoldt, JK; Li, L; Masaki, T; Mohammad, SF; Rathi, R; Zentner, G; Zhuplatov, S | 1 |
| Blindt, R; Franke, A; Haager, PK; Hanrath, P; Hoffmann, R; Iofina, E; Langenberg, R; Ortlepp, JR; Radke, PW; Weber, C | 1 |
| Escolar, E; Fearnot, NE; Hong, MK; Kim, JJ; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Raizner, AE; Weissman, NJ | 2 |
| Choi, CG; He, X; Kim, JS; Kim, TH; Kim, YM; Shin, JH; Song, HY; Suh, JY; Yoon, CJ; Yuk, SH | 1 |
| Acampado, E; Finn, AV; Gold, HK; Guerrero, LJ; Harnek, J; Kolodgie, FD; Skorija, K; Tefera, K; Virmani, R; Weber, DK | 1 |
| Abizaid, A; Aoki, J; Belardi, J; Bonnier, H; Bressers, M; Condado, J; den Heijer, P; Gambone, L; Litvack, F; McClean, D; Pieper, M; Serruys, PW; Sianos, G; Smits, P; Sousa, E; Symons, J; Verheye, S | 1 |
| Ambrose, JA; Coppola, JT; Liuzzo, JP | 1 |
| Argentieri, D; Brosius, R; Carter, D; Falotico, R; Parry, TJ; Siekierka, J; Thyagarajan, R | 1 |
| Bosmans, JM; Bult, H; Cooper, S; De Scheerder, IK; Hendriks, M; Huang, Y; Levels, A; Salu, KJ; Verhoeven, M; Vrints, CJ | 1 |
| Jeon, HJ; Kim, DJ; Kim, SJ; Ko, JY; Kwon, GY; Kwon, T; Lee, BH; Lee, WK; Lim, HJ; Nam, HY; Park, JS | 1 |
| Angiolillo, DJ; Bystron, M; Cervinka, P; Costa, MA; Futamatsu, H; Futamatsu, K; Kvasnák, M; Nanda, H; Spacek, R; Veselka, J | 1 |
| Cho, HJ; Hahn, JY; Kang, HJ; Kim, HS; Kim, JH; Kim, SH; Kim, TY; Park, KW; Park, YB; Zhang, SY | 1 |
| Forrester, JS; Kapoor, N; Lee, MS; Makkar, RR | 1 |
| Ge, J; Huang, Y; Li, W; Liu, H; Liu, X; Qu, X; Sun, A; Yang, W; Zhao, K; Zou, Y | 1 |
| Hasib, L; Jahn, UR; Klocke, R; Kuhlmann, MT; Nikol, S; Pelisek, J; Quang, TH; Scobioala, S; Tian, W | 1 |
| Hansen, HS; Jensen, LO; Klitkou, J; Thayssen, P | 1 |
| Cheong, SS; Han, KH; Hong, MK; Kang, DH; Kim, JJ; Lee, CW; Mintz, GS; Park, DW; Park, SJ; Park, SW; Song, JK; Song, JM; Weissman, NJ | 1 |
| Barsotti, A; Branchitta, G; Ciabatti, N; Cortese, B; De Carlo, M; Gherarducci, G; Gistri, R; Papini, B; Petronio, AS | 1 |
| Htay, T; Liu, MW | 1 |
| Ahn, TH; Choi, IS; Chung, WJ; Han, SH; Kang, WC; Koh, KK; Oh, KJ; Shin, EK; Shin, MS | 1 |
| Jin, X; Mei, L; Song, C; Sun, H; Sun, R; Zhang, M; Zhu, D | 1 |
| Finn, AV; Gold, HK; John, MC; Joner, M; Kolodgie, F; Nakazawa, G; Newell, J; Virmani, R | 1 |
| Avelar, RL; Gravett, DM; Kohler, TR; Toleikis, PM | 1 |
| Mintz, GS | 1 |
| Billinger, M; Cook, S; Hess, O; Meier, B; Morger, C; Seiler, C; Togni, M; Vogel, R; Wenaweser, P; Windecker, S | 1 |
| Che, YZ; Jin, X; Jin, Z; Mei, L; Song, CX; Sun, HF | 1 |
| Alfonso, F; Angiolillo, DJ; Bass, TA; Corros, C; Costa, MA; Futamatsu, H; Hernandez-Antolin, R; Jimenez-Quevedo, P; Kawaguchi, R; Macaya, C; Sabate, M; Suzuki, N | 1 |
| Morrissey, NJ | 1 |
| Bonaros, N; Bonatti, J; Heiss, S; Laufer, G; Schachner, T; Steger, C; Sterlacci, W | 1 |
| Hong, SJ; Jeon, GS; Jeon, HJ; Kim, CH; Lee, SH; Park, SW; Yi, JG | 1 |
| Ahn, Y; Cho, JG; Hong, SN; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Kim, W; Lee, SR; Park, HW; Park, JC | 1 |
| Li, QL; Li, YK; Sun, KK; Xie, DH; Yuan, L; Zhang, T; Zhang, XM; Zhao, KQ | 1 |
| Ahn, Y; Hong, SJ; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Lim, DS; Lim, SY; Moon, JY | 1 |
| Bonaros, N; Bonatti, J; Heiss, S; Laufer, G; Mayr, T; Reisinger, P; Schachner, T; Steger, C; Zipponi, D | 1 |
| Markman, M | 1 |
| Bromley, P; Burt, H; Jackson, JK; Machan, LS; McManus, BM; Signore, PE; Wilson, JE | 1 |
| Abella, BS; Brinker, JA; Bunge, KE; Cheng, L; Froehlich, JP; Heldman, AW; Heller, PF; Hruban, RH; Hunter, WL; Jenkins, GM; Kim, DW; Kinsella, JL; Lakatta, EG; Nater, C; Rezai, B; Sollott, SJ; Ware, M | 1 |
| Brinker, JA; Heldman, AW | 1 |
| Bramwell, O; Hong, MK; Kornowski, R; Leon, MB; Ragheb, AO | 1 |
| Arai, T; Gohda, M; Matsuda, T; Nakayama, Y; Noguchi, T; Nonogi, H; Tsutsui, N; Yasuda, S | 1 |
10 review(s) available for paclitaxel and Hyperplasia
| Article | Year |
|---|---|
The Role of Drug-Coated Balloon in Haemodialysis Arteriovenous Fistula Stenosis Management.
Topics: Angioplasty, Balloon; Arteriovenous Fistula; Arteriovenous Shunt, Surgical; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Graft Occlusion, Vascular; Humans; Hyperplasia; Paclitaxel; Renal Dialysis; Time Factors; Treatment Outcome; Vascular Access Devices; Vascular Patency | 2023 |
Drug-Coated Balloons for Infrainguinal Peripheral Artery Disease.
Topics: Angioplasty; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Constriction, Pathologic; Drug-Eluting Stents; Femoral Artery; Humans; Hyperplasia; Long Term Adverse Effects; Neointima; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Vascular Patency | 2016 |
Paclitaxel-eluting balloon: from bench to bed.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Design; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Thrombosis; Treatment Outcome | 2009 |
Drug-eluting stent: importance of clinico-pathological correlations.
Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Inflammation; Neointima; Paclitaxel; Risk Factors; Sirolimus; Thrombosis | 2011 |
Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Linear Models; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2012 |
[Prevention of in-stent restenosis: towards an in situ treatment?].
Topics: Animals; Coronary Restenosis; Drug Delivery Systems; Humans; Hyperplasia; Paclitaxel; Sirolimus; Stents; Tunica Intima | 2004 |
Drug eluting stents in the infrainguinal circulation.
Topics: Animals; Arterial Occlusive Diseases; Femoral Artery; Humans; Hyperplasia; Paclitaxel; Popliteal Artery; Radiography; Recurrence; Sirolimus; Stents; Tunica Intima; Vascular Patency | 2004 |
Drug-eluting stents: the end of restenosis?
Topics: Coronary Restenosis; Humans; Hyperplasia; Metals; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; Tunica Intima | 2004 |
Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Endothelium, Vascular; Humans; Hyperplasia; Immunosuppressive Agents; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Tunica Intima | 2005 |
Drug-eluting stent: a review and update.
Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Carriers; Growth Inhibitors; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; Treatment Outcome; Tunica Intima | 2005 |
31 trial(s) available for paclitaxel and Hyperplasia
| Article | Year |
|---|---|
Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol fo
Topics: Alloys; Amputation, Surgical; Angiography, Digital Subtraction; Angioplasty, Balloon; Ankle Brachial Index; Arterial Occlusive Diseases; Cardiovascular Agents; Clinical Protocols; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Equipment Failure; Femoral Artery; Hemodynamics; Humans; Hyperplasia; Limb Salvage; Neointima; Netherlands; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Prosthesis Failure; Recurrence; Research Design; Resins, Plant; Single-Blind Method; Stents; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Access Devices | 2013 |
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment
Topics: Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Italy; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
Topics: Aged; Cohort Studies; Coronary Angiography; Coronary Stenosis; Double-Blind Method; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prospective Studies; Tunica Intima; Ultrasonography, Interventional | 2014 |
Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Vessels; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome; Tunica Intima; Ultrasonography | 2008 |
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Stents; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2008 |
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Cardiovascular Diseases; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States | 2009 |
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
Topics: Angioplasty, Balloon, Coronary; Asia; Australia; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Europe; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Assessment; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction.
Topics: Adult; Aged; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Myocardial Bridging; Myocardial Infarction; Paclitaxel; Stents; Tunica Intima; Ultrasonography, Interventional | 2010 |
Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Hyperplasia; Male; Metals; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Comparisons of the effects of stent eccentricity on the neointimal hyperplasia between sirolimus-eluting stent versus paclitaxel-eluting stent.
Topics: Aged; Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Tunica Intima; Ultrasonography, Interventional | 2010 |
Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Sirolimus; Tunica Intima; Ultrasonography, Interventional | 2011 |
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Ultrasonography, Interventional | 2011 |
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial.
Topics: Aged; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Saphenous Vein; Ultrasonography, Interventional | 2011 |
Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2012 |
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Endothelial Cells; Equipment Design; Humans; Hyperplasia; Italy; Metals; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Research Design; Stem Cells; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Japan; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States | 2012 |
Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Topics: Cell Division; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Drug Implants; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2003 |
A paclitaxel-eluting stent for the prevention of coronary restenosis.
Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tunica Intima; Ultrasonography, Interventional | 2003 |
Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Tri
Topics: Coronary Restenosis; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Stents; Tunica Intima; Ultrasonography | 2003 |
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
Topics: Angioplasty; Arterial Occlusive Diseases; Arteries; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Metals; Middle Aged; Paclitaxel; Polymers; Stents; Tunica Intima; Ultrasonography | 2004 |
Relation of intimal hyperplasia thickness to stent size in paclitaxel-coated stents.
Topics: Antineoplastic Agents, Phytogenic; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Stents; Tunica Intima; Ultrasonography, Interventional | 2004 |
Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
Topics: Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Humans; Hyperplasia; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tunica Intima; Ultrasonography, Interventional | 2005 |
Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
Topics: Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Humans; Hyperplasia; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tunica Intima; Ultrasonography, Interventional | 2005 |
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
Topics: Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Stents; Time Factors; Tunica Intima; Ultrasonography, Interventional | 2005 |
"Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; Vascular Patency | 2006 |
High sensitive C-reactive protein and interleukin 6 are not related to neointimal hyperplasia in paclitaxel eluting stents or bare metal stents. An intravascular ultrasound study.
Topics: Antineoplastic Agents, Phytogenic; Biomarkers; C-Reactive Protein; Drug Delivery Systems; Humans; Hyperplasia; Interleukin-6; Paclitaxel; Stents; Tunica Intima; Ultrasonography, Interventional | 2007 |
Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
Topics: Coronary Angiography; Coronary Restenosis; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2006 |
Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Stenosis; Female; Follow-Up Studies; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Radiography; Sirolimus; Stents; Tubulin Modulators; Tunica Intima; Ultrasonography, Interventional | 2007 |
Effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a polymer-based paclitaxel-eluting stent: angiographic and IVUS study.
Topics: Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Preoperative Care; Prognosis; Retrospective Studies; Stents; Tunica Intima; Ultrasonography, Interventional | 2007 |
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.
Topics: Analysis of Variance; Coronary Angiography; Coronary Disease; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Hyperplasia; Imaging, Three-Dimensional; Male; Paclitaxel; Prospective Studies; Sirolimus; Stents; Tacrolimus; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2008 |
73 other study(ies) available for paclitaxel and Hyperplasia
| Article | Year |
|---|---|
Endothelial-Smooth Muscle Cell Interactions in a Shear-Exposed Intimal Hyperplasia on-a-Dish Model to Evaluate Therapeutic Strategies.
Topics: Endothelial Cells; Fibronectins; Humans; Hyperplasia; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paclitaxel | 2022 |
Perivascular patch using biodegradable polymers: Investigation of mechanical and drug elution characteristics.
Topics: Drug Delivery Systems; Humans; Hyperplasia; Paclitaxel; Pharmaceutical Preparations; Polyesters; Polymers | 2023 |
Influence of Self-Expanding Paclitaxel-Eluting Stent Sizing on Neointimal Hyperplasia in Superficial Femoral Artery Lesions.
Topics: Aged; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Peripheral Arterial Disease; Prospective Studies; Prosthesis Design; Self Expandable Metallic Stents; Tomography, Optical Coherence; Treatment Outcome | 2020 |
Study on the Role of Paclitaxel Nano-Drug Delivery System in Inhibiting Intimal Hyperplasia and Improving Vascular Remodeling in Abdominal Aortic Injury Model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Endothelial Cells; Hyperplasia; Nanoparticles; Paclitaxel; Rabbits; Vascular Remodeling | 2021 |
Design, Development, In Vitro and Preliminary In Vivo Evaluation of a Novel Photo-Angioplasty Device: Lumi-Solve.
Topics: Angioplasty; Animals; Carotid Artery, Common; Hyperplasia; Neointima; Paclitaxel; Sheep | 2021 |
Paclitaxel-coated stents to prevent hyperplastic proliferation of ureteral tissue: from in vitro to in vivo.
Topics: Animals; Cell Line; Cell Proliferation; Disease Models, Animal; Drug-Eluting Stents; Epithelial Cells; Humans; Hyperplasia; Male; Paclitaxel; Rats; Ureter; Ureteral Obstruction; Urothelium | 2020 |
Gefitinib-coated balloon inhibits the excessive hyperplasia of intima after vascular injuries through PI3K/AKT pathway.
Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carotid Artery Injuries; Coated Materials, Biocompatible; Gefitinib; Hyperplasia; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Vascular System Injuries | 2019 |
Clinical significance of low signal intensity area surrounding stent struts identified by optical coherence tomography.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Immunosuppressive Agents; Japan; Male; Middle Aged; Neointima; Outcome Assessment, Health Care; Paclitaxel; Postoperative Complications; Prospective Studies; Sirolimus; Stents; Tomography, Optical Coherence; Tubulin Modulators | 2013 |
The effect of short-term intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local thrombotic environment after angioplasty.
Topics: Angioplasty, Balloon; Animals; Biopsy, Needle; Carotid Artery Injuries; Carotid Artery, Common; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hyperplasia; Immunohistochemistry; Infusions, Intra-Arterial; Male; Neointima; Paclitaxel; Random Allocation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2013 |
Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Cell Proliferation; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Crystallization; Drug-Eluting Stents; Female; Femoral Artery; Hyperplasia; Iliac Artery; Male; Materials Testing; Models, Animal; Neointima; Paclitaxel; Prosthesis Design; Radiography; Sus scrofa; Wound Healing | 2014 |
Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter.
Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Cardiac Catheters; Coated Materials, Biocompatible; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Equipment Design; Hyperplasia; Male; Paclitaxel; Swine; Tunica Intima | 2014 |
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Topics: Absorbable Implants; Animals; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Hyperplasia; Inflammation; Models, Animal; Neointima; Paclitaxel; Polymers; Sirolimus; Stents; Swine | 2014 |
Paclitaxel coating on the terminal portion of hemodialysis grafts effectively suppresses neointimal hyperplasia in a porcine model.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Carotid Artery, Common; Coated Materials, Biocompatible; Constriction, Pathologic; Disease Models, Animal; Female; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Neointima; Paclitaxel; Polytetrafluoroethylene; Prosthesis Design; Renal Dialysis; Swine; Time Factors | 2015 |
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
Topics: Aged; Angina, Stable; Angina, Unstable; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tubulin Modulators; Ultrasonography, Interventional | 2014 |
Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents.
Topics: Absorbable Implants; Animals; Aorta, Abdominal; Aspirin; Biocompatible Materials; Calcium-Binding Proteins; Calponins; Drug-Eluting Stents; Electrochemical Techniques; Hyperplasia; Lactic Acid; Male; Microfilament Proteins; Nanotechnology; Paclitaxel; Platelet Adhesiveness; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2014 |
Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
Topics: Aged; Angioplasty, Balloon; Blood Flow Velocity; Cardiovascular Agents; Carotid Stenosis; Drug-Eluting Stents; Endovascular Procedures; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prosthesis Design; Recurrence; Regional Blood Flow; Retreatment; Risk Factors; Stents; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler; Vascular Patency | 2014 |
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome; Vascular Remodeling | 2015 |
Pharmacokinetic Evaluation of Two Paclitaxel-Coated Balloons with Different Drug Load in a Short-Term Porcine Study.
Topics: Angioplasty, Balloon; Animals; Coated Materials, Biocompatible; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Iliac Artery; Male; Paclitaxel; Sus scrofa; Swine; Tubulin Modulators | 2016 |
Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
Topics: Angiography; Angioplasty, Balloon; Animals; Coated Materials, Biocompatible; Equipment Design; Femoral Artery; Fibrosis; Hyperplasia; Iliac Artery; Materials Testing; Models, Animal; Neointima; Paclitaxel; Sus scrofa; Swine; Tomography, Optical Coherence; Tunica Intima; Tunica Media; Vasoconstriction; Vasodilation | 2016 |
Local delivery of modified paclitaxel-loaded poly(epsilon-caprolactone)/pluronic F68 nanoparticles for long-term inhibition of hyperplasia.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carotid Arteries; Delayed-Action Preparations; Humans; Hyperplasia; Nanoparticles; Paclitaxel; Particle Size; Poloxamer; Polyesters; Quaternary Ammonium Compounds; Rabbits; Surface Properties | 2009 |
Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Common Bile Duct; Disease Models, Animal; Dogs; Drug-Eluting Stents; Epithelium; Equipment Safety; Hyperplasia; Male; Mucous Membrane; Paclitaxel; Polyurethanes | 2009 |
In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Hyperplasia; Inflammation; Models, Animal; Nickel; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Stents; Swine; Time Factors; Titanium; Wound Healing | 2009 |
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Germany; Humans; Hyperplasia; Logistic Models; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Paclitaxel; Polymers; Prosthesis Design; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima | 2009 |
Immune reactions in the progeny of female rats treated with paclitaxel.
Topics: Animals; Animals, Newborn; Cytostatic Agents; Female; Hyperplasia; Immunity; Male; Paclitaxel; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Thymus Gland; Time Factors | 2008 |
Advanced neointimal growth is not associated with a low risk of in-stent thrombus. Optical coherence tomographic findings after first-generation drug-eluting stent implantation.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima | 2009 |
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Case-Control Studies; Clinical Trials, Phase II as Topic; Cohort Studies; Cyclooxygenase 2; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hyperplasia; Ifosfamide; Immunoenzyme Techniques; Male; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Precancerous Conditions; Prognosis; Survival Rate | 2009 |
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation?
Topics: Animals; Biomechanical Phenomena; Blood Vessel Prosthesis; Cell Proliferation; Hyperplasia; Male; Paclitaxel; Polyesters; Rats; Rats, Sprague-Dawley; Tunica Intima | 2009 |
Comparison of sirolimus and paclitaxel-eluting stents for complex coronary lesions: an intravascular ultrasound study.
Topics: Adult; Aged; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Sirolimus; Tunica Intima; Ultrasonography, Interventional | 2009 |
Lack of association between large angiographic late loss and low risk of in-stent thrombus: angioscopic comparison between paclitaxel- and sirolimus-eluting stents.
Topics: Aged; Angioscopy; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Sirolimus | 2008 |
[Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention].
Topics: Absorbable Implants; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Paclitaxel; Polymers; Tunica Intima | 2010 |
Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Topics: Absorbable Implants; Animals; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Eluting Stents; Hyperplasia; Materials Testing; Paclitaxel; Polyesters; Swine; Tunica Intima | 2010 |
Comparison of the effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a sirolimus- or paclitaxel-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Regression Analysis; Sirolimus; Tubulin Modulators; Tunica Intima; Ultrasonography, Interventional | 2010 |
Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Cell Proliferation; Coronary Vessels; Equipment Design; Hyperplasia; Materials Testing; Microscopy, Fluorescence; Models, Animal; Paclitaxel; Sus scrofa; Tissue Distribution; Tunica Intima | 2010 |
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
Topics: Aged; Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Sirolimus; Tunica Intima; Ultrasonography, Interventional | 2010 |
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional | 2010 |
Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Lipid Metabolism; Male; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Angiography; Drug Carriers; Drug-Eluting Stents; Hyperplasia; Materials Testing; Metals; Nanostructures; Paclitaxel; Polymers; Porosity; Stents; Surface Properties; Swine; Swine, Miniature; Tomography, Optical Coherence; Tunica Intima | 2011 |
Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Carotid Artery, Internal; Carotid Stenosis; Cell Proliferation; Drug-Eluting Stents; Hyperplasia; Metals; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Radiography; Stents; Sus scrofa; Time Factors; Tunica Intima | 2011 |
Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts.
Topics: Animals; Arteriovenous Shunt, Surgical; Carotid Arteries; Cell Proliferation; Constriction, Pathologic; Female; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Models, Animal; Neointima; Paclitaxel; Polytetrafluoroethylene; Renal Dialysis; Sirolimus; Swine; Vascular Grafting | 2012 |
Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Carotid Artery, Common; Cell Movement; Cell Proliferation; Coated Materials, Biocompatible; Drug Carriers; Female; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Myofibroblasts; Paclitaxel; Prosthesis Design; Renal Dialysis; Solubility; Swine; Time Factors; Tunica Intima; Vascular Patency | 2012 |
Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model.
Topics: Administration, Oral; alpha-Tocopherol; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Carotid Artery Injuries; Carotid Stenosis; Catheterization; Cell Division; Ethylene Glycols; Glycerol; Hyperplasia; Infusions, Parenteral; Intestines; Linoleic Acids; Male; Models, Animal; Myocytes, Smooth Muscle; Paclitaxel; Pharmaceutical Vehicles; Polysorbates; Radiography; Rats; Rats, Sprague-Dawley; Recurrence; Surface-Active Agents; Tocopherols; Tunica Intima; Verapamil | 2004 |
Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials).
Topics: Angiogenesis Inhibitors; Coronary Angiography; Coronary Restenosis; Dose-Response Relationship, Drug; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Stainless Steel; Stents; Tunica Intima | 2004 |
Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.
Topics: Animals; Blood Vessel Prosthesis; Dogs; Female; Graft Occlusion, Vascular; Hyperplasia; Male; Paclitaxel; Polymers; Polytetrafluoroethylene; Renal Dialysis; Tunica Intima | 2004 |
Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries.
Topics: Coronary Restenosis; Coronary Vessels; Dexamethasone; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Tunica Intima; Ultrasonography, Interventional | 2004 |
Tissue hyperplasia: influence of a paclitaxel-eluting covered stent--preliminary study in a canine urethral model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Dogs; Hyperplasia; Male; Paclitaxel; Stents; Urethra; Urethral Stricture | 2005 |
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
Topics: Animals; Catheterization; Drug Therapy, Combination; Fibrin; Hyperplasia; Iliac Artery; Inflammation; Paclitaxel; Rabbits; Sirolimus; Stents; Treatment Outcome; Tunica Intima; Wound Healing | 2005 |
Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carotid Artery Injuries; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Hyperplasia; Male; Muscle, Smooth, Vascular; Paclitaxel; Rats; Rats, Inbred Lew; Sirolimus; Stents; Tunica Intima | 2005 |
Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
Topics: Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Angiography; Coronary Restenosis; Cytochalasin D; Dose-Response Relationship, Drug; Hyperplasia; Macrophages; Microscopy, Electron; Models, Animal; Muscle, Smooth, Vascular; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Platelet Aggregation; Rabbits; Random Allocation; Stents; Swine; Tunica Intima | 2006 |
Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Disease Models, Animal; Fluorocarbon Polymers; Graft Occlusion, Vascular; Hyperplasia; In Vitro Techniques; Male; Paclitaxel; Prosthesis Design; Renal Dialysis; Swine; Tunica Intima | 2006 |
The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Differentiation; Cell Proliferation; Endothelium, Vascular; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Hyperplasia; Immunohistochemistry; Male; Models, Animal; Paclitaxel; Rabbits; Recombinant Proteins; Stents; Tunica Intima; Wound Healing | 2006 |
The Janus face of drug-eluting stents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Endothelium, Vascular; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hyperplasia; Paclitaxel; Rabbits; Recombinant Proteins; Stents; Wound Healing | 2006 |
Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Arsenic Trioxide; Arsenicals; Blood Vessel Prosthesis Implantation; Cell Cycle; Cell Proliferation; Coated Materials, Biocompatible; Flow Cytometry; Growth Inhibitors; Hyperplasia; Iliac Artery; Male; Microscopy, Electron, Scanning; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxides; Paclitaxel; Rabbits; Stents; Tunica Intima | 2006 |
Paclitaxel delivered to adventitia attenuates neointima formation without compromising re-endothelialization after angioplasty in a porcine restenosis model.
Topics: Analysis of Variance; Angioplasty, Balloon; Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Connective Tissue; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Femoral Artery; Fluorescent Antibody Technique; Graft Occlusion, Vascular; Hyperplasia; Immunohistochemistry; Injections, Intra-Arterial; Ki-67 Antigen; Myocytes, Smooth Muscle; Paclitaxel; Platelet Endothelial Cell Adhesion Molecule-1; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Swine; Tunica Intima; Tunica Media; von Willebrand Factor | 2006 |
Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carotid Artery Injuries; Catheterization; Chromatography, High Pressure Liquid; Diffusion; Disease Models, Animal; Endothelium, Vascular; Hyperplasia; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size; Polyglactin 910; Polyvinyl Alcohol; Rabbits; Solubility; Time Factors; Treatment Outcome; Tunica Intima | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Drug Implants; Drug Utilization; Endothelium, Vascular; Equipment Design; Equipment Failure; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Tunica Intima; Wound Healing | 2007 |
Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh.
Topics: Anastomosis, Surgical; Animals; Arteriovenous Shunt, Surgical; Cardiovascular Agents; Drug Delivery Systems; Graft Occlusion, Vascular; Hyperplasia; Male; Models, Animal; Paclitaxel; Prostheses and Implants; Random Allocation; Surgical Mesh; Treatment Failure; Tunica Intima; Vascular Patency | 2007 |
What to do about late incomplete stent apposition?
Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Contrast Media; Coronary Aneurysm; Coronary Thrombosis; Drug Implants; Equipment Failure; Follow-Up Studies; Humans; Hyperplasia; Multicenter Studies as Topic; Paclitaxel; Sirolimus; Sodium Chloride; Stents; Tunica Intima; Ultrasonography, Interventional | 2007 |
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Drug Implants; Equipment Failure; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Time Factors; Tunica Intima; Ultrasonography, Interventional | 2007 |
[Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carotid Artery Injuries; Catheterization; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Female; Hyperplasia; Lactic Acid; Male; Nanoparticles; Nanotechnology; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Tunica Intima | 2007 |
Biological treatment of vein grafts and stents in lower-extremity arterial reconstruction.
Topics: Arterial Occlusive Diseases; Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Hyperplasia; Leg; Oligonucleotides; Paclitaxel; Radiography; Tunica Intima; Vascular Patency | 2007 |
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
Topics: Actins; Aged; Aged, 80 and over; Coronary Artery Bypass; Desmin; Dose-Response Relationship, Drug; Drug-Eluting Stents; Elastic Tissue; Female; Humans; Hyperplasia; Ki-67 Antigen; Male; Middle Aged; Organ Culture Techniques; Paclitaxel; Saphenous Vein; Tubulin Modulators; Tunica Intima | 2007 |
Inhibition of pseudointimal hyperplasia in swine TIPS models: the efficacy of local delivery of paclitaxel using a perforated balloon catheter.
Topics: Angioplasty, Balloon; Animals; Antineoplastic Agents, Phytogenic; Catheterization; Disease Models, Animal; Drug Delivery Systems; Hepatic Veins; Hyperplasia; Paclitaxel; Portasystemic Shunt, Transjugular Intrahepatic; Swine; Treatment Outcome | 2007 |
Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.
Topics: Abciximab; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arteries; Constriction, Pathologic; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Female; Hyperplasia; Immunoglobulin Fab Fragments; Inflammation; Paclitaxel; Sirolimus; Swine; Tunica Intima | 2007 |
[The pilot study of the effect of paclitaxel by local slow delivery on intimal hyperplasia of vascular anastomosis after vascular graft bypass].
Topics: Anastomosis, Surgical; Animals; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Dogs; Hyperplasia; Paclitaxel; Pilot Projects; Postoperative Period; Surgical Stomas; Tunica Intima | 2007 |
Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis.
Topics: Animals; Cell Proliferation; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Female; Hyperplasia; Inflammation; Paclitaxel; Sirolimus; Stents; Swine; Tunica Intima | 2008 |
Connective tissue changes in a mouse model of vein graft disease.
Topics: Animals; Apoptosis; Carotid Arteries; Collagen; Connective Tissue; Glycosaminoglycans; Graft Occlusion, Vascular; Hyperplasia; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Paclitaxel; Thrombosis; Tunica Intima; Vena Cava, Inferior | 2008 |
Eighty-seventh annual meeting of the American Association for Cancer Research. Washington, D,C., 20-24 April 1996.
Topics: Aged; Antineoplastic Agents; Breast; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Genes, p53; Genes, Tumor Suppressor; Humans; Hyperplasia; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neovascularization, Pathologic; Paclitaxel; Pancreatic Neoplasms; Research; Survival Rate | 1996 |
Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries.
Topics: Angiogenesis Inhibitors; Angioplasty, Balloon; Animals; Carotid Artery, Common; Hyperplasia; Paclitaxel; Rats; Rats, Wistar; Tunica Intima | 2001 |
Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
Topics: Animals; Coronary Angiography; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Graft Occlusion, Vascular; Hyperplasia; Infusion Pumps, Implantable; Male; Paclitaxel; Stents; Surface Properties; Swine, Miniature; Tunica Intima | 2001 |
The messenger and the message: Preventing restenosis.
Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Graft Occlusion, Vascular; Hyperplasia; Paclitaxel; Stents; Swine | 2001 |
Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model.
Topics: Angiogenesis Inhibitors; Animals; Coronary Angiography; Coronary Vessels; Disease Models, Animal; Graft Occlusion, Vascular; Hyperplasia; Paclitaxel; Stents; Swine; Tunica Intima | 2001 |
Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model.
Topics: Administration, Topical; Analysis of Variance; Animals; Antineoplastic Agents; Catheterization; Docetaxel; Drug Delivery Systems; Hyperplasia; Iliac Artery; Image Processing, Computer-Assisted; Leukocyte Count; Paclitaxel; Rabbits; Taxoids; Tunica Intima | 2002 |